Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRK
9. MRNA
10. NTES

Go back to Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial
(NASDAQ: KROS) Delayed: 10.95 -0.15 (1.35%)
Previous Close $11.10    52 Week High $ 
Open $11.09    52 Week Low $ 
Day High $11.10    P/E N/A 
Day Low $10.55    EPS $ 
Volume 203,075